Primary Mammary Angiosarcoma in a Postmenopausal Woman: A Case Report

IF 2.5 Q4 ONCOLOGY
Cancer reports Pub Date : 2026-09-09 DOI:10.1002/cnr2.70653
Tingting Liu, Yueqin Xu, Qingwei Wang, Shiya Yu, Hongming Lin, Zeyi Ye, Zhiqiang Zheng, Changan Yang, Tianzi Hong
{"title":"Primary Mammary Angiosarcoma in a Postmenopausal Woman: A Case Report","authors":"Tingting Liu,&nbsp;Yueqin Xu,&nbsp;Qingwei Wang,&nbsp;Shiya Yu,&nbsp;Hongming Lin,&nbsp;Zeyi Ye,&nbsp;Zhiqiang Zheng,&nbsp;Changan Yang,&nbsp;Tianzi Hong","doi":"10.1002/cnr2.70653","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Primary breast angiosarcoma (PAS) is a rare aggressive mesenchymal breast tumor, which predominantly affects young premenopausal women and is prone to misdiagnosis due to nonspecific clinical and imaging features. Surgical resection is the main treatment, while the efficacy of adjuvant chemoradiotherapy remains unclear. Targeted therapy represents a promising novel therapeutic direction.</p>\n </section>\n \n <section>\n \n <h3> Case</h3>\n \n <p>A 51-year-old postmenopausal woman presented with a rapidly enlarging left breast mass for over 3 months. Physical examination showed a 4 cm × 3 cm × 2 cm mass with a smooth surface, moderate mobility and no cutaneous changes. The lesion was radically resected via two-stage surgery, and the patient was diagnosed with stage I (T1N0M0) primary left breast angiosarcoma. The patient received sequential adjuvant chemotherapy with doxorubicin plus cyclophosphamide followed by paclitaxel. No recurrence or metastasis occurred during more than 5 years of follow-up.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Different from conventional PAS predominantly occurring in young women, this atypical postmenopausal PAS has high concealment and diagnostic difficulty. This study summarizes the clinical characteristics and diagnostic pitfalls of this rare case, supplements the clinical and prognostic data of postmenopausal PAS, and helps improve clinicians' recognition of atypical PAS to avoid delayed diagnosis and treatment.</p>\n </section>\n </div>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":"9 9","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cnr2.70653","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70653","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Primary breast angiosarcoma (PAS) is a rare aggressive mesenchymal breast tumor, which predominantly affects young premenopausal women and is prone to misdiagnosis due to nonspecific clinical and imaging features. Surgical resection is the main treatment, while the efficacy of adjuvant chemoradiotherapy remains unclear. Targeted therapy represents a promising novel therapeutic direction.

Case

A 51-year-old postmenopausal woman presented with a rapidly enlarging left breast mass for over 3 months. Physical examination showed a 4 cm × 3 cm × 2 cm mass with a smooth surface, moderate mobility and no cutaneous changes. The lesion was radically resected via two-stage surgery, and the patient was diagnosed with stage I (T1N0M0) primary left breast angiosarcoma. The patient received sequential adjuvant chemotherapy with doxorubicin plus cyclophosphamide followed by paclitaxel. No recurrence or metastasis occurred during more than 5 years of follow-up.

Conclusion

Different from conventional PAS predominantly occurring in young women, this atypical postmenopausal PAS has high concealment and diagnostic difficulty. This study summarizes the clinical characteristics and diagnostic pitfalls of this rare case, supplements the clinical and prognostic data of postmenopausal PAS, and helps improve clinicians' recognition of atypical PAS to avoid delayed diagnosis and treatment.

绝经后妇女原发性乳腺血管肉瘤1例报告。
背景:原发性乳腺血管肉瘤(Primary breast angiosarcoma, PAS)是一种罕见的侵袭性乳腺间充质肿瘤,主要发生在年轻绝经前妇女,由于临床和影像学特征不明确,易误诊。手术切除是主要治疗方法,辅助放化疗的疗效尚不清楚。靶向治疗是一个很有前景的治疗新方向。病例:51岁绝经后妇女,左乳肿块迅速增大3个多月。体格检查显示一个4 cm × 3 cm × 2 cm的肿块,表面光滑,活动适中,无皮肤改变。通过两期手术彻底切除病变,患者被诊断为I期(T1N0M0)原发性左乳血管肉瘤。患者接受阿霉素加环磷酰胺序贯辅助化疗,再辅以紫杉醇。随访5年以上无复发或转移。结论:与以年轻女性为主的传统PAS不同,这种不典型绝经后PAS具有较高的隐蔽性和诊断难度。本研究总结了该罕见病例的临床特点及诊断误区,补充了绝经后PAS的临床及预后资料,有助于提高临床医生对非典型PAS的认识,避免延误诊断和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer reports
Cancer reports Medicine-Oncology
CiteScore
2.70
自引率
5.90%
发文量
160
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书